Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekBioPharma Dive ↗
Dazodalibep, acquired in Amgen's big buyout of Horizon Therapeutics, succeeded in the first of two late-stage …
The WeekPharmaVoice ↗
While M&A expands one-stop shop capabilities at large CROs, pharma companies could face tradeoffs around n…
The WeekFiercePharma ↗
The president announced plans to split some childhood immunizations in the U.S. into five separate shots, give…
The WeekFierceBiotech ↗
A phase 2 trial of Roche's dual GLP-1/GIP receptor agonist has hit its primary endpoints, painting the drug ca…
The WeekBriefing
Multiple reports said senior officials discussed an executive order that would give an external panel power to…
The WeekDrug Channels ↗
By Bryce Platt, PharmD For more than a decade, the answer to "Where do drug wholesalers make their money?" has…
The WeekSTAT News ↗
The race between Amy Acton and Vivek Ramaswamy could be the election's most direct test of where the heartland…
The WeekBioPharma Dive ↗
Beacon claimed the findings represent the first time a treatment for X-linked retinitis pigmentosa, a rare and…
The WeekPharmaVoice ↗
The government has announced pricing agreements with 26 pharma companies. But the deals could stymie other pla…
The WeekFiercePharma ↗
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…
The WeekFierceBiotech ↗
Telix has struck a deal to buy ITM Isotope Technologies Munich for $1.65 billion upfront, securing an R&D …
The WeekBriefing
The new Rural Health Transformation Program gives all 50 states access to grants through 2030. The catch is th…
The WeekDrug Channels ↗
Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services C…
The WeekSTAT News ↗
Under investor pressure, Novo presented its strategy to both grow its obesity franchise and diversify its pipe…
The WeekPharmaceutical Technology ↗
Telix Pharmaceuticals has agreed to acquire ITM Isotope Technologies Munich in a transaction valued at up to $…
The WeekBioPharma Dive ↗
New GLP-1 therapy indications mean new challenges for pharma companies, from care to consumer trust.…
The WeekFiercePharma ↗
The CHMP recommendation for Novo's next gen hemophilia A treatment was one of several noteworthy endorsements …
The WeekFierceBiotech ↗
New-look Novo is digging deeper into its metabolic roots with three new obesity programs purchased from New Yo…
The WeekBriefing
STAT’s Sept. 18 roundup pointed to Roche, a gene therapy approval in Sanfilippo syndrome, and mixed Xenon Phar…
The WeekSTAT News ↗
The Jehovah's Witnesses have partly eased their longstanding prohibition on the medical use of donated blood.…
The WeekFiercePharma ↗
With longer progression-free survival, Jake Van Naarden, president of Lilly Oncology, told Fierce he expects m…
The WeekFierceBiotech ↗
Artelo Biosciences' oral dual cannabinoid agonist showed weight loss comparable to the GLP-1 semaglutide in ob…
The WeekBriefing
North Immunology is joining Aethlon Biotech in a reverse merger, bringing $180 million and a dual-acting eczem…
The WeekSTAT News ↗
Every state will participate in the GENEROUS program, but many of the details are unknown.…
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.